This webinar focuses on the development of new oncogene drivers upon progression and resistance. Dr. Zofia Piotrowska and Dr. Catherine Meador, both from Massachusetts General in Boston, provide their expertise. Watch the video here.
We are a group of lung cancer patients with EGFR mutations who have developed resistance to at least one targeted treatment drug, or who face probable resistance in the future. Caregivers are also welcome. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.